William Blair maintains Outperform rated on Cabaletta Bio Inc. (CABA) amid trial progress
Tweet Send to a Friend
William Blair analyst Sami Corwin reiterated an Outperform rating on Cabaletta Bio Inc. (NASDAQ: CABA)The analyst commented, "In our view ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
